The Business Case for GLP-1s: Adherence, ROI & Population Health | Milken Institute 2026
At the Milken Institute Global Conference 2026, eMed CEO Linda Yaccarino and Lisa Stevens, Chief Administrative Officer at Aon, ...... utilization of these GLP-1 therapies to drive the best health health outcomes that's how Lisa Stevens and AON and EMED came ...